Medable

Palo Alto, CA · United States

Contract Research Organizationmid

Specialization: Decentralized Trial Platform

Key Differentiator

Market leader in DCT technology; 300+ trials in 60 countries, 120 languages, 1M+ patients; ~80% revenue growth (2024); Everest Group Leader; $521M total funding

Core Services

AI-powered DCT platform, eCOA, eConsent, remote patient monitoring, telehealth visits, Medable Studio (no-code), Medable AI/Studio, CRO Partner Program, sensor/wearable integration

Capabilities

AI powered DCT platformeCOAeConsentremote patient monitoringtelehealth visitsMedable Studio (no code)Medable AI/StudioCRO Partner Programsensor/wearable integration

Market Intelligence

DCT platform market: ~$2B (2024); North America = 75%+ global share

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.